{"id":866688,"date":"2025-07-07T02:26:08","date_gmt":"2025-07-07T06:26:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\/"},"modified":"2025-07-07T02:26:08","modified_gmt":"2025-07-07T06:26:08","slug":"wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\/","title":{"rendered":"WST Shareholders Have the Right to Lead the West Pharmaceutical Services, Inc. Securities Lawsuit &#8211; Contact the DJS Law Group to Discuss Your Rights &#8211; WST"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">LOS ANGELES<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">July 7, 2025<\/span><\/span> \/PRNewswire\/ &#8212; <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4462865-1&amp;h=424770829&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4249451-1%26h%3D2037481888%26u%3Dhttps%253A%252F%252Fdjslawllp.com%252F%26a%3DThe%2BDJS%2BLaw%2BGroup&amp;a=The+DJS+Law+Group\" target=\"_blank\" rel=\"nofollow\">The DJS Law Group<\/a>\u00a0reminds investors of a class action lawsuit against West Pharmaceutical Services, Inc. (&#8220;West&#8221; or &#8220;the Company&#8221;) (NYSE: WST) for violations of the federal securities laws.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/2725221\/DJS_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2725221\/DJS_Logo.jpg\" title=\"DJS Law Group\" alt=\"DJS Law Group\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>Shareholders\u00a0who purchased the Company&#8217;s securities between <span class=\"xn-chron\">February 16, 2023<\/span> and <span class=\"xn-chron\">February 12, 2025<\/span>, inclusive (the &#8220;Class Period&#8221;), are encouraged to contact the firm before <span class=\"xn-chron\">July 7, 2025<\/span>.<\/p>\n<p>\n        <b>CASE DETAILS:<\/b>\u00a0\u00a0The complaint <span>alleges<\/span> that the Company made false and misleading statements to the market concerning whether West claimed to have strong visibility into customer demand, but suffered from significant destocking of its High-Value Products portfolio. The Company&#8217;s SmartDose device, purportedly a high-margin product, was in fact dilutive of its profit margins due to inefficiencies. The Company suffered margin pressures increasing the risk of restructuring such as exiting continuous glucose monitoring contacts with long-term customers.<\/p>\n<p>If you are a shareholder who suffered a loss,\u00a0<a href=\"mailto:David@djslawllp.com\" target=\"_blank\" rel=\"nofollow\">contact us to participate<\/a>.<\/p>\n<p>\n        <b>WHY DJS LAW GROUP?<\/b>\u00a0DJS Law Group&#8217;s primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic\/international M&amp;A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.<\/p>\n<p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.<\/p>\n<p>\n        <b>CONTACT:<\/b>\n      <\/p>\n<p>\n        <span class=\"xn-person\">David J. Schwartz<\/span>\n      <\/p>\n<p>DJS Law Group<\/p>\n<p>274 White Plains Road, Suite 1<\/p>\n<p>\u00a0Eastchester, NY 10709<\/p>\n<p>Phone: 914-206-9742<\/p>\n<p>Email:\u00a0<a href=\"mailto:David@djslawllp.com\" target=\"_blank\" rel=\"nofollow\">David@djslawllp.com<\/a><\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA24601&amp;sd=2025-07-07\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit---contact-the-djs-law-group-to-discuss-your-rights---wst-302498517.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit&#8212;contact-the-djs-law-group-to-discuss-your-rights&#8212;wst-302498517.html<\/a><\/p>\n<p>SOURCE  DJS Law Group LLP<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LA24601&amp;Transmission_Id=202507070223PR_NEWS_USPR_____LA24601&amp;DateId=20250707\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire LOS ANGELES , July 7, 2025 \/PRNewswire\/ &#8212; The DJS Law Group\u00a0reminds investors of a class action lawsuit against West Pharmaceutical Services, Inc. (&#8220;West&#8221; or &#8220;the Company&#8221;) (NYSE: WST) for violations of the federal securities laws. Shareholders\u00a0who purchased the Company&#8217;s securities between February 16, 2023 and February 12, 2025, inclusive (the &#8220;Class Period&#8221;), are encouraged to contact the firm before July 7, 2025. CASE DETAILS:\u00a0\u00a0The complaint alleges that the Company made false and misleading statements to the market concerning whether West claimed to have strong visibility into customer demand, but suffered from significant destocking of its High-Value Products portfolio. The Company&#8217;s SmartDose device, purportedly a high-margin product, was in fact dilutive of its profit margins due to inefficiencies. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;WST Shareholders Have the Right to Lead the West Pharmaceutical Services, Inc. Securities Lawsuit &#8211; Contact the DJS Law Group to Discuss Your Rights &#8211; WST&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-866688","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>WST Shareholders Have the Right to Lead the West Pharmaceutical Services, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - WST - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"WST Shareholders Have the Right to Lead the West Pharmaceutical Services, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - WST - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire LOS ANGELES , July 7, 2025 \/PRNewswire\/ &#8212; The DJS Law Group\u00a0reminds investors of a class action lawsuit against West Pharmaceutical Services, Inc. (&#8220;West&#8221; or &#8220;the Company&#8221;) (NYSE: WST) for violations of the federal securities laws. Shareholders\u00a0who purchased the Company&#8217;s securities between February 16, 2023 and February 12, 2025, inclusive (the &#8220;Class Period&#8221;), are encouraged to contact the firm before July 7, 2025. CASE DETAILS:\u00a0\u00a0The complaint alleges that the Company made false and misleading statements to the market concerning whether West claimed to have strong visibility into customer demand, but suffered from significant destocking of its High-Value Products portfolio. The Company&#8217;s SmartDose device, purportedly a high-margin product, was in fact dilutive of its profit margins due to inefficiencies. &hellip; Continue reading &quot;WST Shareholders Have the Right to Lead the West Pharmaceutical Services, Inc. Securities Lawsuit &#8211; Contact the DJS Law Group to Discuss Your Rights &#8211; WST&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-07T06:26:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2725221\/DJS_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"WST Shareholders Have the Right to Lead the West Pharmaceutical Services, Inc. Securities Lawsuit &#8211; Contact the DJS Law Group to Discuss Your Rights &#8211; WST\",\"datePublished\":\"2025-07-07T06:26:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\\\/\"},\"wordCount\":301,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2725221\\\/DJS_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\\\/\",\"name\":\"WST Shareholders Have the Right to Lead the West Pharmaceutical Services, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - WST - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2725221\\\/DJS_Logo.jpg\",\"datePublished\":\"2025-07-07T06:26:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2725221\\\/DJS_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2725221\\\/DJS_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"WST Shareholders Have the Right to Lead the West Pharmaceutical Services, Inc. Securities Lawsuit &#8211; Contact the DJS Law Group to Discuss Your Rights &#8211; WST\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"WST Shareholders Have the Right to Lead the West Pharmaceutical Services, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - WST - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\/","og_locale":"en_US","og_type":"article","og_title":"WST Shareholders Have the Right to Lead the West Pharmaceutical Services, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - WST - Market Newsdesk","og_description":"PR Newswire LOS ANGELES , July 7, 2025 \/PRNewswire\/ &#8212; The DJS Law Group\u00a0reminds investors of a class action lawsuit against West Pharmaceutical Services, Inc. (&#8220;West&#8221; or &#8220;the Company&#8221;) (NYSE: WST) for violations of the federal securities laws. Shareholders\u00a0who purchased the Company&#8217;s securities between February 16, 2023 and February 12, 2025, inclusive (the &#8220;Class Period&#8221;), are encouraged to contact the firm before July 7, 2025. CASE DETAILS:\u00a0\u00a0The complaint alleges that the Company made false and misleading statements to the market concerning whether West claimed to have strong visibility into customer demand, but suffered from significant destocking of its High-Value Products portfolio. The Company&#8217;s SmartDose device, purportedly a high-margin product, was in fact dilutive of its profit margins due to inefficiencies. &hellip; Continue reading \"WST Shareholders Have the Right to Lead the West Pharmaceutical Services, Inc. Securities Lawsuit &#8211; Contact the DJS Law Group to Discuss Your Rights &#8211; WST\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\/","og_site_name":"Market Newsdesk","article_published_time":"2025-07-07T06:26:08+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2725221\/DJS_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"WST Shareholders Have the Right to Lead the West Pharmaceutical Services, Inc. Securities Lawsuit &#8211; Contact the DJS Law Group to Discuss Your Rights &#8211; WST","datePublished":"2025-07-07T06:26:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\/"},"wordCount":301,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2725221\/DJS_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\/","name":"WST Shareholders Have the Right to Lead the West Pharmaceutical Services, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - WST - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2725221\/DJS_Logo.jpg","datePublished":"2025-07-07T06:26:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2725221\/DJS_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2725221\/DJS_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wst-shareholders-have-the-right-to-lead-the-west-pharmaceutical-services-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-wst\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"WST Shareholders Have the Right to Lead the West Pharmaceutical Services, Inc. Securities Lawsuit &#8211; Contact the DJS Law Group to Discuss Your Rights &#8211; WST"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/866688","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=866688"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/866688\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=866688"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=866688"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=866688"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}